• All
  • Primary Antibodies
  • Conjugated Antibodies for IF
  • Conjugated Antibodies for FC
  • Secondary Antibodies
  • Antibody Labeling KitsNew
  • ELISA Kits
  • IHC Kits
  • Magnetic Cell Separation Kits
  • Cytokines & Growth Factors
  • Neutralizing/activating Antibodies
  • Nanobody-based Reagents
  • Accessory Products and Kits
  • Fusion Proteins
×
×
Host
0
Species Reactivity
0
Species Reactivity
0
Conjugate
0
Conjugate
0
Compatible Species
0
Conjugate
0

CLCN3 Polyklonaler Antikörper

CLCN3 Polyklonal Antikörper für WB, Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus

Anwendung

WB, Indirect ELISA

Konjugation

Unkonjugiert

Kat-Nr. : 55330-1-PBS

Synonyme

ClC 3, CLC3

Filter:
  • Western Blot (WB) analysis of various lysates using CLCN3 Polyclonal antibody (55330-1-AP)

    WB analysis using 55330-1-AP (same clone as 55330-1-PBS)

    Various lysates were subjected to SDS PAGE followed by western blot with 55330-1-AP (CLCN3 antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours. This data was developed using the same antibody clone with 55330-1-PBS in a different storage buffer formulation.

Geprüfte Anwendungen

Produktinformation

55330-1-PBS bindet in WB, Indirect ELISA CLCN3 und zeigt Reaktivität mit human, Maus

Getestete Reaktivität human, Maus
Wirt / Isotyp Kaninchen / IgG
Klonalität Polyklonal
Typ Antikörper
Immunogen Peptid
Vollständiger Name chloride channel 3
Berechnetes Molekulargewicht 91 kDa
Beobachtetes Molekulargewicht90-100 kDa
GenBank-ZugangsnummerNM_001829
Gene symbol CLCN3
Gene ID (NCBI) 1182
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Antigen-Affinitätsreinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

Chloride channel 3 (CLCN3), one of the members of the chloride channel family that are voltage-gated, primarily regulates the homeostasis state of intercellular ions and the acidification of cellular compartments. CLCN3 has been shown to function in cell proliferation, migration, and resistance to pharmacological treatment in glioma, ovarian cancer, and stomach adenocarcinoma cells. Therefore, CLCN3 may function critically in the initiation and development of cancer. (PMID: 36439880)